Business Issue
Following the acquisition of Pharmacy OneSource, Wolters Kluwer tasked Andy Strunk with integrating its newly expanded portfolio of healthcare products—including industry leaders like UpToDate, ProVation Order Sets, and Lexidrug—into a cohesive and value-driven offering.
The challenge extended beyond product alignment to include team integration, as the acquisition brought together disparate business units with different operational cultures and priorities.
To ensure the success of the post-M&A integration, Wolters Kluwer required a strategy that would foster collaboration, drive innovation, and deliver measurable accretive value, reinforcing the investment thesis to shareholders.
Action Taken
Mr. Strunk led the corporate innovation lab, leveraging intrapreneurship and cross-functional collaboration to build trust across business unit leaders and their teams. By assembling and leading a new team composed of talent from across portfolio companies, he established a culture of shared purpose and innovation to maximize impact. Key initiatives delivered:
- Cross-Portfolio Integration & Team Building: Designed a collaborative framework that aligned product roadmaps, business models, and go-to-market strategies while bringing together disparate teams to operate as one cohesive unit.
- Sepsis Reduction Initiative: Identified and led the development of a sepsis reduction project as the first major post-merger innovation, leveraging insights from multiple portfolio products to showcase the power of cross-team collaboration.
- New Product Development & Revenue Growth: Launched Point of Care Advisor, a net-new offering that not only expanded recurring subscription revenues but also strengthened team cohesion by rallying multiple business units around a shared success.
When Pharmacy OneSource was acquired by Wolters Kluwer, Andy’s impact was undeniable—he was retained and elevated to lead their Corporate Innovation Lab, where he shaped the future of digital health solutions within a global organization.
One of Andy’s most impressive accomplishments was championing an early-stage sepsis detection solution and carrying it forward through to launch. Andy earned the trust of business unit leaders across Wolters Kluwer’s healthcare portfolio, aligning them around a shared vision to bring a seamless, high-impact solution to market. His ability to synthesize complex challenges into clear, actionable strategies proved instrumental in delivering a solution that saved lives and strengthened Wolters Kluwer’s leadership in clinical decision support.
His work earned him the prestigious Wolters Kluwer Innovation Award, a testament to Andy’s ability to drive innovation at scale and execute transformative ideas that create measurable impact.
If your organization is tackling a high-stakes initiative, Andy is the partner you need. His ability to bridge vision and execution is unmatched, and I highly recommend reaching out to him to explore how he can bring the same level of success to your business.
Keith Streckenbach
Serial Entrepreneur and CEO of Pharmacy Stars
Impact Delivered
By integrating business units, fostering collaboration, and driving innovation, Wolters Kluwer successfully executed strategies that enhanced shareholder confidence and delivered measurable financial impact:
- Generated net-new revenues through the launch of Point of Care Advisor, demonstrating accretive value creation within the Health portfolio.
- Expanded ARR (Annual Recurring Revenue) contributions, both from the new product and increased subscriptions to existing portfolio offerings.
- Built a high-performing, post-M&A integrated team, breaking down silos and instilling a culture of shared purpose and innovation.
- Strengthened shareholder and board confidence, providing a concrete case for the strategic success of the acquisition.
By successfully aligning business units, fostering team cohesion, and expanding recurring revenues, Wolters Kluwer maximized the value of its acquisition and established a strong foundation for future growth in the healthcare technology sector.
